Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net income		$ 88,000	$ 79,981
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property and equipment		809	1,407
Amortization of trademarks and other intangibles		1,724	2,468
Amortization of deferred financing costs and debt discount		2,459	2,711
Amortization of convertible note discount		15,069	14,428
Stock-based compensation expense		5,888	8,247
Non-cash gain on re-measurement of equity investment		(49,990)	(28,897)
Provision for doubtful accounts		3,918	1,956
Equity earnings on joint ventures		(2,650)	(6,043)
Distributions from equity investments		1,333	4,767
Gain on sale of trademarks	[1]		(6,399)
Deferred income tax provision		21,403	25,497
Foreign currency translation loss (gain)		(8,769)	367
Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable		(14,713)	(27,651)
Other assets – current		16,746	2,955
Other assets		1,569	(11,958)
Deferred revenue		4,741	3,087
Accounts payable and accrued expenses		7,727	13,198
Net cash provided by operating activities		95,264	80,121
Cash flows used in investing activities:
Purchases of property and equipment		(802)	(778)
Proceeds from sale of trademarks and related notes receivable		3,030	4,000
Proceeds from sale of fixed assets		225
Additions to trademarks		(108)	(273)
Net cash used in investing activities		(153,819)	(35,938)
Cash flows (used in) provided by financing activities:
Shares repurchased on the open market		(12,391)	(144,312)
Proceeds from Variable Funding Notes		100,000
Payment of long-term debt		(30,562)	(30,624)
Proceeds from sale of trademarks and related notes receivable from consolidated JVs		10,317	5,170
Additional payment to Purim		(2,000)
Distributions to non-controlling interests		(9,016)	(10,046)
Excess tax benefit from share-based payment arrangements		54	1,172
Cost of shares repurchased on vesting of restricted stock and exercise of stock options		(3,156)	(13,971)
Proceeds from exercise of stock options and warrants			3,440
Restricted cash		(5,363)	(1,696)
Net cash provided by (used in) financing activities		47,883	(190,867)
Effect of exchange rate changes on cash		576	(242)
Net decrease in cash and cash equivalents		(10,096)	(146,926)
Cash and cash equivalents, beginning of period		128,039	278,789
Cash and cash equivalents, end of period		117,943	131,863
Income taxes (net of refunds received)		(6,284)	10,623
Interest		23,736	24,756
Non-cash investing and financing activities:
Sale of trademarks for note receivable			22,138
Restricted Stock
Non-cash investing and financing activities:
Shares repurchased on vesting of restricted stock included in accrued expenses		11,436
iBrands International LLC
Cash flows used in investing activities:
Acquisition of interest			(2,500)
Iconix China
Cash flows used in investing activities:
Acquisition of interest		(20,400)
Non-cash investing and financing activities:
Issuance of shares in connection with purchase of Iconix China		15,703
Pony International, LLC.
Cash flows used in investing activities:
Acquisition of interest		(37,000)
Strawberry Shortcake
Cash flows used in investing activities:
Acquisition of interest		(95,000)
Non-cash investing and financing activities:
Note receivable in connection with Strawberry Shortcake acquisition		8,370
Iconix Latin America
Cash flows used in investing activities:
Acquisition of interest			(42,000)
American Greetings Corporation
Cash flows used in investing activities:
Issuance of note		(10,000)
Proceeds received from note		1,250
Buffalo International Unlimited Liability Corporation
Cash flows used in investing activities:
Proceeds received from note		$ 4,986	$ 5,613

[1] Gains on sale of trademarks was previously reported as other revenue. Many of the gains recorded upon formation of certain joint ventures were reversed as a result of consolidation. The gains that were not impacted by consolidation, and therefore not reversed, have been reclassified and are being presented as a separate line item above operating income.